Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Salvage treatment of relapsed or refractory germ-cell tumours - authors' reply.

Wessalowski R, Schneider DT, Göbel U, Calaminus G; MAKEI study group.

Lancet Oncol. 2013 Nov;14(12):e486-7. doi: 10.1016/S1470-2045(13)70474-1. No abstract available.

PMID:
24176561
2.

Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.

Wessalowski R, Schneider DT, Mils O, Friemann V, Kyrillopoulou O, Schaper J, Matuschek C, Rothe K, Leuschner I, Willers R, Schönberger S, Göbel U, Calaminus G; MAKEI study group.

Lancet Oncol. 2013 Aug;14(9):843-52. doi: 10.1016/S1470-2045(13)70271-7. Epub 2013 Jul 1.

PMID:
23823158
3.

Testicular sex cord stromal tumors: analysis of patients from the MAKEI study.

Hofmann M, Schlegel PG, Hippert F, Schmidt P, von-Schweinitz D, Leuschner I, Göbel U, Calaminus G, Schneider DT; MAKEI study group.

Pediatr Blood Cancer. 2013 Oct;60(10):1651-5. doi: 10.1002/pbc.24607. Epub 2013 Jun 3.

PMID:
23733594
4.

Germ cell tumors of the head and neck: report from the MAKEI Study Group.

Bernbeck B, Schneider DT, Bernbeck B, Koch S, Teske C, Lentrodt J, Harms D, Göbel U, Calaminus G; MAKEI-Study Group.

Pediatr Blood Cancer. 2009 Feb;52(2):223-6. doi: 10.1002/pbc.21752.

PMID:
18937314

Supplemental Content

Loading ...
Support Center